MINERVA NEUROSCIENCES INC's ticker is NERV and the CUSIP is 603380106. A total of 87 filers reported holding MINERVA NEUROSCIENCES INC in Q2 2020. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $836,000 | -5.5% | 480,629 | +26.0% | 0.08% | -15.0% |
| Q2 2021 | $885,000 | +128.7% | 381,488 | +187.5% | 0.10% | +56.2% |
| Q1 2021 | $387,000 | +42.8% | 132,670 | +14.4% | 0.06% | +45.5% |
| Q4 2020 | $271,000 | +344.3% | 116,010 | +1050.8% | 0.04% | +193.3% |
| Q1 2020 | $61,000 | -84.4% | 10,081 | -81.6% | 0.02% | -67.4% |
| Q4 2019 | $391,000 | +44.3% | 54,933 | +14.1% | 0.05% | +53.3% |
| Q2 2019 | $271,000 | -52.0% | 48,160 | -32.8% | 0.03% | -47.4% |
| Q1 2019 | $564,000 | +8.0% | 71,707 | -7.4% | 0.06% | -5.0% |
| Q4 2018 | $522,000 | -37.2% | 77,400 | +16.9% | 0.06% | +30.4% |
| Q3 2018 | $831,000 | +581.1% | 66,200 | +313.8% | 0.05% | +475.0% |
| Q3 2017 | $122,000 | -76.5% | 16,000 | -72.7% | 0.01% | -76.5% |
| Q2 2017 | $519,000 | +61.7% | 58,600 | +48.0% | 0.03% | +100.0% |
| Q1 2017 | $321,000 | – | 39,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,652,436 | $31,166,000 | 4.20% |
| NEXTHERA CAPITAL LP | 492,958 | $5,792,000 | 3.40% |
| Iguana Healthcare Management, LLC | 150,000 | $1,763,000 | 1.05% |
| Perceptive Advisors | 810,537 | $9,523,000 | 0.68% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,141,333 | $13,411,000 | 0.63% |
| FEDERATED HERMES, INC. | 6,358,642 | $74,714,000 | 0.22% |
| EAM Investors, LLC | 137,685 | $1,618,000 | 0.22% |
| Orbimed Advisors | 556,200 | $6,535,000 | 0.08% |
| J. Goldman & Co LP | 103,281 | $1,214,000 | 0.08% |
| Virtus ETF Advisers LLC | 18,814 | $221,000 | 0.07% |